STOCK TITAN

Avantor Stock Price, News & Analysis

AVTR NYSE

Company Description

Avantor Inc. (AVTR) manufactures and distributes high-performance materials and chemistries for life sciences and advanced technology applications. Headquartered in Center Valley, Pennsylvania, the company serves pharmaceutical manufacturers, research laboratories, semiconductor producers, and testing facilities through recognized brands including J.T.Baker, Macron Fine Chemicals, Rankem, Benesphera, and POCH.

Life Sciences Solutions

Avantor provides critical materials for pharmaceutical production, supporting drug development from research stages through commercial manufacturing. The company's laboratory research products serve academic institutions, quality control operations, and medical testing facilities. These materials include ultra-pure chemicals, reference standards, and analytical reagents designed for precision applications where contamination risks must be minimized.

Advanced Technology Applications

In the electronics sector, Avantor supplies specialty materials for semiconductor manufacturing processes. The production of microchips requires exceptionally pure chemicals to prevent defects during photolithography, etching, and deposition steps. The company's materials meet the stringent specifications demanded by chipmakers where even trace impurities can compromise circuit performance.

Global Distribution Model

The company operates through a distribution network spanning multiple continents, delivering both proprietary formulations and third-party products. This hybrid model allows Avantor to serve as a single-source supplier for laboratories requiring diverse material types. The business combines manufacturing capabilities with supply chain expertise to maintain inventory availability for time-sensitive applications.

Business Segments

Avantor generates revenue through two primary channels: proprietary products manufactured under its own brands, and distribution of complementary materials from other suppliers. The proprietary portfolio focuses on high-purity chemicals and specialized formulations where quality standards exceed commodity-grade alternatives. The distribution segment addresses broader laboratory needs, providing convenience through consolidated ordering and delivery.

Industry Position

The analytical instrument manufacturing sector requires consistent material quality as laboratories rely on standardized inputs for reproducible results. Avantor serves this need across pharmaceutical development, where regulatory compliance depends on validated materials, and semiconductor production, where manufacturing yields correlate directly with input purity. The company's role centers on bridging chemical suppliers with end-users who demand both technical specifications and supply reliability.

Market Dynamics

Demand for Avantor's products tracks with pharmaceutical research spending and semiconductor fabrication capacity expansion. Biotech companies developing new therapeutics require specialized reagents throughout discovery and clinical trials. Semiconductor manufacturers expanding production facilities create sustained demand for ultra-pure process chemicals. The company benefits from industries where material quality directly impacts final product performance and regulatory approval.

Stock Performance

$—
0.00%
0.00
Last updated:
-44.23 %
Performance 1 year

Insider Radar

Net Buyers
90-Day Summary
537,500
Shares Bought
0
Shares Sold
3
Transactions
Most Recent Transaction
MEHRA SANJEEV K (Director) bought 350,000 shares @ $11.09 on Dec 5, 2025
Based on SEC Form 4 filings over the last 90 days.

Financial Highlights

$6,783,600,000
Revenue (TTM)
$711,500,000
Net Income (TTM)
$840,800,000
Operating Cash Flow

Upcoming Events

JAN
14
January 14, 2026 Marketing

J.P. Morgan Healthcare presentation

CEO Emmanuel Ligner presenting; live audio webcast at ir.avantorsciences.com; replay available 30 days
FEB
01
February 1, 2026 Corporate

Advisory role ends

FEB
11
February 11, 2026 Earnings

Q4 & FY2025 results release

Results released before market open; webcast at https://ir.avantorsciences.com
FEB
11
February 11, 2026 Earnings

Earnings conference call

Live audio webcast at https://ir.avantorsciences.com; replay available for 30 days

Short Interest History

Last 12 Months
Loading short interest data...

Days to Cover History

Last 12 Months
Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Avantor (AVTR)?

The current stock price of Avantor (AVTR) is $12.6 as of January 13, 2026.

What is the market cap of Avantor (AVTR)?

The market cap of Avantor (AVTR) is approximately 8.4B. Learn more about what market capitalization means .

What is the revenue (TTM) of Avantor (AVTR) stock?

The trailing twelve months (TTM) revenue of Avantor (AVTR) is $6,783,600,000.

What is the net income of Avantor (AVTR)?

The trailing twelve months (TTM) net income of Avantor (AVTR) is $711,500,000.

What is the earnings per share (EPS) of Avantor (AVTR)?

The diluted earnings per share (EPS) of Avantor (AVTR) is $1.04 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Avantor (AVTR)?

The operating cash flow of Avantor (AVTR) is $840,800,000. Learn about cash flow.

What is the profit margin of Avantor (AVTR)?

The net profit margin of Avantor (AVTR) is 10.49%. Learn about profit margins.

What is the operating margin of Avantor (AVTR)?

The operating profit margin of Avantor (AVTR) is 15.99%. Learn about operating margins.

What is the gross margin of Avantor (AVTR)?

The gross profit margin of Avantor (AVTR) is 33.60%. Learn about gross margins.

What is the current ratio of Avantor (AVTR)?

The current ratio of Avantor (AVTR) is 1.07, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of Avantor (AVTR)?

The gross profit of Avantor (AVTR) is $2,279,300,000 on a trailing twelve months (TTM) basis.

What is the operating income of Avantor (AVTR)?

The operating income of Avantor (AVTR) is $1,084,800,000. Learn about operating income.

What products does Avantor manufacture?

Avantor produces high-performance chemicals, analytical reagents, and specialty materials under brands including J.T.Baker, Macron Fine Chemicals, Rankem, Benesphera, and POCH. These products serve pharmaceutical production, laboratory research, and semiconductor manufacturing applications requiring exceptional purity standards.

What industries does Avantor serve?

Avantor serves the life sciences sector including pharmaceutical manufacturers, biotech research facilities, academic laboratories, and medical testing operations. The company also supplies the electronics industry with materials for semiconductor fabrication processes.

How does Avantor generate revenue?

Avantor generates revenue through two channels: manufacturing proprietary high-purity chemicals and specialty formulations, and distributing complementary laboratory materials from third-party suppliers. This hybrid model positions the company as a comprehensive supplier for diverse laboratory needs.

Where is Avantor headquartered?

Avantor is headquartered in Center Valley, Pennsylvania. The company operates a global distribution network serving customers across multiple continents.

What makes Avantor's chemicals different from commodity chemicals?

Avantor's chemicals meet ultra-pure specifications required for applications where even trace contaminants affect results. Pharmaceutical production demands validated materials for regulatory compliance, while semiconductor manufacturing requires exceptional purity to prevent circuit defects during chip fabrication.

What role does Avantor play in pharmaceutical development?

Avantor supplies critical materials throughout the drug development lifecycle, from early research through commercial manufacturing. Pharmaceutical companies rely on consistent, high-quality reagents and reference standards to ensure reproducible results and meet regulatory requirements.

How does Avantor support semiconductor manufacturing?

Avantor provides specialty chemicals for semiconductor fabrication processes including photolithography, etching, and deposition. Chipmakers require exceptionally pure materials as contaminants can compromise circuit performance and reduce manufacturing yields.

What is Avantor's business model?

Avantor combines chemical manufacturing with distribution services, offering both proprietary formulations and third-party products. This approach allows laboratories to consolidate suppliers while accessing both specialized materials and standard laboratory consumables through a single source.